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DegradationThis review aims to provide an overview of current knowledge on stabilization of proteins by sugars in
the solid state in relation to stress conditions commonly encountered during drying and storage. First
protein degradation mechanisms in the solid state (i.e. physical and chemical degradation routes) and
traditional theories regarding protein stabilization (vitrification and water replacement hypotheses) will
be briefly discussed. Secondly, refinements to these theories, such as theories focusing on local mobility
and protein-sugar packing density, are reviewed in relationship to the traditional theories and their
analogies are discussed. The last section relates these mechanistic insights to the stress conditions against
which these sugars are used to provide protection (i.e. drying, temperature, and moisture). In summary
sugars should be able to adequately form interactions with the protein during drying, thereby maintain-
ing it in its native conformation and reducing both local and global mobility during storage. Generally
smaller sugars (disaccharides) are better at forming these interactions and reducing local mobility as they
are less inhibited by steric hindrance, whilst larger sugars can reduce global mobility more efficiently.
The principles outlined here can aid in choosing a suitable sugar as stabilizer depending on the protein,
formulation and storage condition-specific dominant route of degradation.
 2017 The Authors. Published by Elsevier B.V. This is anopenaccess article under the CCBY license (http://
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Over the past decades, the importance of protein therapeutics
for the pharmaceutical industry has grown from a nearly negligible
role to being a primary focus. As proteins are generally not stable
for prolonged periods of time, formulation scientists faced many
challenges in achieving sufficient shelf life for these protein thera-
peutics [1,2]. A lot of these challenges have been overcome, as is
illustrated by the fact that in 2015 nearly 30% of drugs newly reg-
istered at the United States Food and Drug Administration (FDA)
were protein drugs [3]. However, all but 1 of these protein drugs
are liquid formulations which require refrigerated (2–8 C) storage
and transportation, the so-called cold chain, whereas the remain-
ing dry powder formulation (mepoluzimab, Nucala) must be
stored and transported below 25 C, see Table 1.
Maintaining the cold chain regime is costly and particularly
provides difficulties in remote areas of developing, often tropical,
countries [4]. One of the proven strategies to overcome this, is to
dry proteins in the presence of stabilizers like sugars [5–7]. The
number of licensed lyophilized protein drugs has also steadily
grown, Table 2 provides an overview of lyophilized protein drugs
which received a biological license approval by the FDA since
2011. A plethora of research on the topic of drying proteins with
sugars has been published by scientists from food and pharmaceu-
tical sciences, describing various aspects of how these sugars
stabilize proteins. This review aims to provide an overview of the
current knowledge regarding the mechanisms behind stabilization
of proteins by sugars in the solid state in relationship to stress con-
ditions commonly encountered during production and storage.
First protein degradation mechanisms and traditional theories
regarding protein stabilization will be briefly discussed; secondly
refinements to these theories and how they come together will
be reviewed. The last section will relate stress conditions to how
sugars protect against them.2. Degradation
Degradation of proteins commonly leads to a loss of functional-
ity and formation of potentially immunogenic products [8]. To
understand stabilization of proteins an understanding of how pro-
teins can degrade is important. Therefore, the main mechanisms of
degradation of proteins, classified as either physical or chemical
degradation, will be addressed here briefly. For more in-depth
information the reader is directed to several extensive reviews
on this topic [2,9–11].
The most common physical degradation mechanisms are
denaturation and noncovalent aggregation. Denaturation is the
unfolding of the three-dimensional structure of the protein. This
can be caused by various stresses such as heat, shear stress,Table 1
Overview of protein drugs newly registered at the United States Food and Drug Administr
Protein Trade name Type
Alirocumab Praluent Mono






Insulin degludec Tresiba Horm
Mepolizumab Nucala Mono
Necitumumab Portrazza Mono
Recombinant human parathyroid hormone Natpara Horm
Sebelipase alfa Kanuma Enzym
Secukinumab Cosentyx Monoexposure to interfaces, or chemical factors [2,9]. Denaturation can
occur in the solid state but is more likely to happen when the pro-
tein is dissolved in a liquid and during drying [5,6,9,12,13]. Gener-
ally in the native conformation hydrophobic parts of the protein are
folded inward and unfolding/denaturation results in these groups
being exposed on the outside of the protein’s three-dimensional
structure [9]. The increased surface area and exposed hydrophobic
groups of unfolded or partially refolded proteins increase the risk of
adsorption and non-covalent aggregation [1,14]. Therefore, non-
native proteins have a higher tendency to aggregate than native
proteins [15,16]. Aggregation is in most cases irreversible [1].
Furthermore, aggregates in liquid formulations can be qualified as
either soluble or insoluble and when aggregate size increases, sed-
imentation (or floating) will eventually occur [12].
Important chemical degradation mechanisms include covalent
aggregation, deamidation, oxidation, and Maillard browning.
Chemical covalent aggregation, rather than physical non-covalent
aggregation, is the predominant route of aggregation in the solid
state [17,18]. Chemical aggregation is in most cases linked to a
thiol-disulfide interchange in the protein, and is accelerated by
residual moisture or exposure to atmospheric water. Many other
chemical degradation mechanisms (i.e. oxidation, deamidation,
Maillard browning) are also dependent on moisture content (see
Section 4.3). Other factors affecting these chemical degradation
reactions include storage temperature, excipients, the physical
state of the excipients (e.g. liquid, amorphous, crystalline), and
obviously the chemical composition of the protein [11]. In the con-
text of stabilizing proteins with sugars, Maillard browning is of
particular interest as it involves reducing sugars. Maillard brown-
ing starts with a reaction between the aldehyde or ketone group
of the reducing sugar and the amino group of the protein forming
a Schiff’s base and is followed by a cascade of reactions eventually
leading to the formation of covalent aggregates [19].3. Theories on stabilization by sugars
Two theories on the mechanism of stabilization of sugars on
proteins in the solid state, the vitrification theory and water
replacement theory, have been around for several decades and
have been widely discussed in literature [20,21]. More recently,
refinements and new theories focusing on global and local mobility
of the protein, molecular flexibility of the sugar, and protein-sugar
miscibility on a molecular level have been published.
3.1. Classic theories: vitrification and water replacement
Stabilization of bioactive proteins is traditionally based on two
approaches: the vitrification theory which describes alterations in
reaction kinetics and the water replacement theory which is basedation (FDA) in 2015, their type, physical form, and storage temperatures [3].
Form Storage temperature
clonal antibody Liquid 2–8 C
e Liquid 2–8 C
clonal antibody Liquid 2–8 C
clonal antibody Liquid 2–8 C
clonal antibody Liquid 2–8 C
clonal antibody Liquid 2–8 C
clonal antibody Liquid 2–8 C
one Liquid 2–8 C
clonal antibody Lyophilized powder >0 C; <25 C
clonal antibody Liquid 2–8 C
one Liquid 2–8 C
e Liquid 2–8 C
clonal antibody Liquid 2–8 C
Table 2
Lyophilized protein drugs approved for marketing by the FDA (Biologics License Agreement (BLA)) between 2011 and 2016. Approval and product information from www.fda.gov













52.5 mg 735 mg trehalose Seattle genetics 153 2011
58.8 mg sodium citrate dihydrate
2.21 mg citric acid





For 400 mg formulation GSK 147 2011
400 mg sucrose
13.5 mg sodium citrate
2.0 mg citric acid
0.8 mg polysorbate 80
Blincyto Blinatumomab Monoclonal
antibody
35 mg 95.5 mg trehalose dehydrate Amgen 54 2014
23.23 mg lysine hydrochloride
3.35 mg citric acid monohydrate
0.64 mg polysorbate 80
Entyvio Vedolizumab Monoclonal
antibody
300 mg 500 mg sucrose Takeda 147 2014
131.7 mg L-arginine hydrochloride
23 mg L-histidine
21.4 mg L-histidine monohydrochloride
3 mg polysorbate 80
Erwinaze Asparaginase
Erwinia chysanthemi
Enzyme 10.000 IU 5.0 mg glucose monohydrate Jazz
Pharmaceuticals
35 2011
0.5 mg sodium chloride
Inflectra Infliximab-dyyb Monoclonal
antibody
100 mg 500 mg sucrose Pfizer 149 2016
6.1 mg disodium hydrogen phosphate dihydrate
2.2 mg sodium dihydrogen phosphate monohydrate







For 160mg formulation Genentech 149 2013
480 mg sucrose
1.6 mg polysorbate 20
0.08 mmoles sodium succinate
Keytruda Pembrolizumab Monocolonal
antibody
50 mg 140 mg sucrose Merck 149 2014
3.1 mg L-histidine
0.4 mg polysorbate 80
Optional sodium hydroxide or hydrochloric acid








100 mg 160 mg sucrose GSK 149 2015
7.14 mg sodium phosphate dibasic heptahydrate
0.67 mgPolysorbate 80
Nulojix Belatacept Fusion protein 250 mg 500 mg sucrose Bristol-Myers
Squibb
90 2011
34.5 mg monobasic sodium phosphate





For 400mg formulation: Janssen 145 2014
14.9 mg L-histidine (from L-histidine and L-histidine
monohydrochloride monohydrate)
3.2 mg polysorbate
Voraxaze Glucarpidase Enzyme 1000
units




0.002 mg Zinc acetate dihydrate
290 M.A. Mensink et al. / European Journal of Pharmaceutics and Biopharmaceutics 114 (2017) 288–295on (equilibrium) thermodynamic considerations. The vitrification
theory is based on the concept of immobilizing the protein in a
rigid, amorphous glassy sugar matrix and by doing so drastically
slowing down degradation [20]. Unfolding and most other modes
of degradation require molecular mobility of the protein and are
thus slowed down by vitrification [22]. A striking example of vitri-
fication in nature is the preservation of insects in amber for up to
tens of millions of years [23]. Thus, the vitrification theory
describes stabilization from a kinetic perspective. Sugar glasses
are characterized by a glass transition temperature (Tg), above
which the kinetic immobilization and therewith also the stabiliz-
ing power of the sugar are largely lost [24]. In addition, crystalliza-
tion of small molecules such as the sugar can occur when the
system is in the rubbery state (i.e. above the Tg) and this can havedetrimental effects on proteins [25,26]. Water plays a vital role as
it drastically reduces the Tg of sugar glasses [27].
The water replacement theory describes stabilization from a
thermodynamic point of view [9]. It encompasses the concept that
during drying the hydroxyl groups of the sugar form hydrogen
bonds with the protein, thereby replacing hydrogen
bonds between water and the protein. By this replacement of
hydrogen bonds the protein’s native conformation is maintained
[21,28–31]. Carpenter and Crowe showed that the ability of a sugar
to prevent shifts of the amide II band, indicative of protein sec-
ondary structure and hydrogen bonding, during drying correlated
with their ability to stabilize enzymes during drying [21].
Vitrification and water replacement both result in preservation
of the structure of the protein, by preventing molecular mobility
M.A. Mensink et al. / European Journal of Pharmaceutics and Biopharmaceutics 114 (2017) 288–295 291and by preventing changes in protein structure, respectively
[32,33]. Grasmeijer and coworkers showed that as long as there
is sufficient vitrification, i.e. a Tg of at least 10–20 C above the
storage temperature, water replacement is the predominant mech-
anism of stabilization. However, when the storage temperature is
closer to or over the Tg, vitrification becomes the limiting factor
for stability [34]. This illustrates that both theories have their
merit, but also that both cannot fully explain protein stabilization
on their own, leaving room for further refinements.3.2. Refinements of theories
3.2.1. Local versus global mobility
Recently, it has been shown that local mobility (b relaxation) of
specific groups of the protein can be more predictive of protein sta-
bility than the global mobility (a relaxation), on which the vitrifi-
cation theory is based [35–37]. This was further confirmed using
anti-plasticizers, additives which can increase global mobility
whilst reducing local mobility, and plasticizers, which increase
both global and local mobility [38]. The predictive capacity of b
relaxations are presumed to be derived from coupling of b relax-
ations to local molecular mobility of the protein, and coupling to
diffusion rates of small molecule reactive species in the glass
[38]. b relaxations can be measured with neutron backscattering,
but unfortunately facilities for neutron backscattering measure-
ments are not available for routine testing. A potential alternative
benchtop method using time-resolved fluorescence Stokes-shift
has been proposed, which is currently under development [39,40].
One could hypothesize that global mobility correlates with
physical degradation and local mobility correlates with chemical
degradation, as for physical degradation mobility on a larger scale
is needed and for chemical degradation mobility of specific groups
of the protein is more relevant. As a rule of thumb, this concept
seems to hold some truth, but it was also shown that this distinc-
tion cannot be made so generally as different routes of chemical
degradation require mobility on different length scales and global
mobility can also play a role there [41,42]. However, when the
degradation routes of a protein and the therefore required types
of mobility are known, it should be possible to come up with
targeted strategies to prevent these degradations based on the con-
cepts illustrated above.3.2.2. Packing density and interactions
Several research groups have explored why some sugars are
better water replacers than other sugars and/or further looked into
the concept and consequences of water replacement. It was shown
that smaller and molecularly more flexible oligosaccharides (i.e.
those with more flexible backbones) were better able to stabilize
four model proteins during storage after lyophilization than their
larger and molecularly more rigid counterparts [43]. Additionally,
these smaller and molecularly more flexible sugars formed more
hydrogen bonds with the protein during freeze-drying [31]. This
was proposed to be due to the fact that these sugars are less ster-
ically hindered in interacting with the protein and could therefore
achieve a tighter packing with the protein [43]. A logical conse-
quence of stronger interactions and a tighter packing are increased
density and thus a decreased free volume of these formulations.
Using positron annihilation lifetime spectroscopy (PALS) it was
shown that addition of maltose to a maltopolymer reduced free
volume and molecular dynamics simulations showed that free vol-
ume increased with increasing molecular weight for amorphous
maltodextrins [44,45]. Additionally, density of amorphous dextran
powders was found to increase with decreasing molecular weight
of the polysaccharide as measured by gas pycnometry [46]. It is
most likely that the same principles apply for protein-sugarmixtures, with smaller sugars reducing free volume by filling smal-
ler ‘cavities’ of the protein structure.
It is evident that protein-sugar interactions are essential for
protein stabilization. Lesser known is the fact that next to replacing
hydrogen bonds, sugars can also interact with aromatic protein
residues via their CH groups [47]. These so-called CH-p interac-
tions are highly relevant for protein-ligand binding but they also
play a (modest) role in protein stabilization [48]. Given that inter-
actions are essential, miscibility of protein and sugars on a molec-
ular level is an absolute requirement for successful stabilization.
Phase separation between protein and sugar after freezing and
lyophilization has been reported [49,50]. Protein-sugar miscibility
decreased with increasing sugar size for formulations with a model
protein, IgG, and reduced miscibility correlated with increased
protein aggregation [49]. Factors of the freezing process, such as
sugar concentration and degree of supersaturation prior to freez-
ing, can also be of influence on phase separation [50]. When
phase-separation or partial phase-separation occurs during
freeze-drying, one might expect a change in the amount of protein
found on the solid-air interface. Using surface analysis it was
shown that the estimated amount of protein present at the solid-
air interface varied for different protein-sugar combinations and
correlated with storage stability of the protein [51,52]. For spray-
dried protein-sugar formulations it was shown that proteins are
relatively more abundant on the dried particle surface compared
to in the center because they are surface active and because during
drying the protein’s relatively large size inhibits them from diffus-
ing away from the drying interface as fast as smaller sugars [53,54].
Increasing the amount of sugar in the formulation or adding sur-
factants to the formulation could reduce the relative presence of
proteins on the particle surface.
Phase separation can also occur in the solid state by crystalliza-
tion of one of the components. As mentioned in Section 3.1, it is
widely recognized that crystallization of the sugar in an amorphous
protein-sugar formulation is detrimental for protein structure. This
is because the crystallization process causes a loss of interactions
and induces shear stresses on the protein [25,55,56]. Crystallization
can occur when the storage temperature is higher than the glass
transition temperature, yet then still some sugars have a lower
tendency to crystallize than other sugars [55]. Therefore a low ten-
dency to crystallize is desired in addition to a native glass transition
temperature high enough to achieve a glass transition temperature
of the formulation higher than the storage temperature for protein
stabilizing sugars.
3.3. Common grounds
The above illustrates that stabilization of proteins by sugars is a
complex puzzle which cannot be solved by a single hypothesis and
that the different theories each describe stabilization from a differ-
ent perspective. Moreover, one stabilization approach has more
than one effect from a mechanistic perspective. For example, water
replacement describes how hydrogen bonding is responsible for
protein stabilization, yet hydrogen bonding also implies close con-
tact of the sugar with the protein by which a reduction in local
mobility of (reactive) protein groups is achieved [24,57]. Similarly,
the preservation of protein structure is ascribed to the water
replacement hypothesis, but is equally relevant in the vitrification
theory. Because if vitrification is lost and crystallization occurs,
hydrogen bonds between sugar and protein will also be broken,
resulting in loss of stabilization according to both mechanisms.
Conversely, with sufficient vitrification but limited or no protein-
sugar interactions, protein structure is also lost [31,36,58]. In that
sense, the sugar could simplistically be seen as a scaffolding
around the protein, inhibiting protein movement locally (water
replacement, reduction of local mobility) and more globally by
292 M.A. Mensink et al. / European Journal of Pharmaceutics and Biopharmaceutics 114 (2017) 288–295its rigidity (vitrification) [43]. Not surprisingly, this representation
also does not completely explain protein stabilization, as it does
not account for reactions of the protein with other molecules
(i.e. oxygen, water, sugar, impurities) which could be present in
and/or diffuse through the sugar matrix [59]. Therefore, it is
important to relate the protein stabilizing capacity of the sugars
to specific stress conditions and degradation pathways.
4. Stresses during production and storage
Proteins are produced as solutions and thus require drying to
become solids. The most important stress factors against which
sugars can be used as stabilizers are dehydration stress, tempera-
ture and moisture. In this section, those stresses will be discussed
within the framework of the above presented theories. Stresses
against which sugars do not provide specific protection, such as
shear stress, acidity and photodegradation will not be discussed
here. For more information regarding those topics, the reader is
directed to the reviews of Manning et al. (2010), Chang et al.
(2009), and Cicerone et al. (2015).
4.1. Drying
It is essential that stabilization is effective during drying, as
degradation of the protein during drying can accelerate degrada-
tion during subsequent storage [42]. Proteins can be dried using
a range of techniques, with lyophilization (freeze-drying) and
spray drying being the most frequently used techniques [60,61].
In pharmaceutical industry, lyophilization is the most used tech-
nique as it is generally less stressful to the protein and can be part
of an aseptic process, whereas spray-drying is more frequently
used for food purposes for economic reasons [60,62]. In spray-
drying a solution is atomized by pumping it through a nozzle
and exposing it to hot air, causing evaporation of the moisture
and thus drying. In freeze-drying, the solution is frozen and water
is subsequently removed by sublimation under a vacuum. These
two processes subject the protein to fundamentally different stres-
ses. Spray-drying exposes the protein to shear (during atomiza-
tion), heat, air-liquid interfacial, and dehydration stresses; where
lyophilisation is associated with freezing, dehydration and solid-
liquid interfacial stresses [60,63]. It can be assumed that sugars
are not effective against shear and interfacial stresses, for which
surfactants are a frequently used as protectant [2,64]. Sugars can
be more useful in protecting against dehydration, freezing and
thermal stress [28,65–68]. Here again, stabilization depends on
the characteristics of the sugars, as the stabilization is based on
forming interactions with the protein and reducing global and local
mobility. It deserves extra mention here that drying conditions, e.g.
the freezing rate in lyophilization, are also very important to max-
imize protein stabilization and these conditions should thus be
chosen carefully [13,67].
Additionally, differences in solubility of different components
form a potential issue during drying. For example, when sodium
phosphate buffer is frozen one of the components can precipitate,
resulting in a pH drop of up to 3 units, which is clearly problematic
for protein formulations [69]. The same principle possibly also
explains the observed reduced miscibility of larger sugars (i.e.
polysaccharides) with proteins described in Section 3.2.2. Of course,
the processing parameters of drying (drying rate, time, tempera-
tures etc.) influence the stresses of drying and thus how much
degradation occurs during drying [70–72]. Therefore, an optimized
combination of formulation and processing should be chosen to
maximize protein stability [73]. The effectiveness of different sug-
ars as stabilizers probably also depends on the drying process used
and other formulation choices such as the used protein-sugar ratio.
It was for example recently shown that the stabilizing capacity ofdisaccharide sucrose depended on the protein-sugar ratio used,
contrasting to a homologous disaccharide trehalose which did not
show such a dependency [74]. The stabilizing capacity of sugars is
commonly compared by drying proteins with different sugars in
the same protein-sugar ratio with the same drying regime for all
formulations. It is possible that if optimized drying regimes and
protein-sugar ratio were to be used for the different sugars,
different results could be obtained. We therefore think that further
elucidation of the interplay between drying regime and other for-
mulation aspects with stabilization by sugars with different charac-
teristics would be valuable.
4.2. Temperature
Thermal stress is considered a major stress factor for dry
protein formulations, as degradation generally increases with tem-
perature and one of the reasons to dry proteins in the first place
can be to circumvent the cold chain. In the liquid state, proteins
are characterized by a ‘melting’ temperature (Tm), above which
they rapidly unfold and lose their functionality [75]. For solid state
proteins dried in the presence of sugars the Tg is the temperature
above which the degradation rate increases rapidly. In general
degradation is not as rapid after surpassing the Tg as it is after sur-
passing the Tm in the liquid state. Above the Tm the free energy
change associated with the transition from folded to unfolded is
negative, making the unfolded state thermodynamically favorable.
Surpassing the Tg is characterized by an increase in global mobil-
ity; it is a kinetic process. Hence, it does not necessarily lead to
immediate degradation [55,75].
Degradation can also occur below the Tm and Tg, albeit much
more slowly and not mainly by unfolding. Both chemical and phys-
ical degradation (see Section 2) can potentially occur below these
transition temperatures [2,22]. The mechanism of stabilization of
sugars against thermal stress has largely been explained in Sec-
tion 3.3 and relies on forming an immobilizing matrix around the
protein, which ultimately reduces local and global mobility, result-
ing in protein structure preservation [43,76]. For physical degrada-
tion the concept of reduced mobility can be easily imagined as for
those routes of degradation molecular mobility of the protein is
required and this is strongly reduced by vitrification. For chemical
degradation this link is not as obvious. It has been suggested that
chemical degradation is reduced by sugars through a reduction of
solubility and reduction of diffusion of small molecule reactive
species in the glass as well as by a reduction of local protein
motions [24,38].
Unfortunately, just adding any sugar to a protein and drying
does not guarantee protein stabilization, as not all sugars are
equally good at stabilizing proteins. To maximize stabilization,
the choice of sugar and the method of drying are of particular inter-
est. As mentioned, to achieve more interactions (i.e. hydrogen
bonding) and therewith a reduction of local mobility, smaller
sugars usually are more suitable [31]. However, for vitrification,
which is also required, larger sugars (oligo- and polysaccharides)
are generally more suited. Therefore, a balance should be found
where sufficient vitrification is maintained (i.e. a formulation Tg
of around 10–20 C above storage temperature), whilst maximizing
reduction of local mobility [34]. Ideally, one would therefore use a
relatively small sugar with a relatively high glass transition
temperature and a good ability hydrogen bond with the protein,
such as trehalose. If a higher Tg is desired, this can be achieved by
combining large polysaccharides with smaller disaccharides (anti-
plasticization of the polysaccharide) or by using oligosaccharides
of a desired chain length [24,43,77,78]. During drying, the mole-
cules are immobilized in a random orientation, in which free vol-
ume is relatively high. As a tighter packing is better for reduction
of molecular mobility, this is not ideal. Raising the temperature
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(annealing), can be used to reduce this free volume and with that
local mobility [79,80].4.3. Moisture
Next to temperature, moisture generally has a major impact on
protein stability in the dry state. Water acts as a strong plasticizer,
drastically reducing the Tg (indicative of global mobility) and
increasing local mobility [36,81,82]. As a consequence, it can accel-
erate degradation below the Tg or cause a formulation to surpass
its Tg with previously explained detrimental consequences
[11,83]. Below the Tg, increasing moisture levels mostly speed up
chemical degradation reactions, like covalent aggregation, deami-
dation and oxidation [11,18]. Above the Tg, the increase in global
mobility has a larger impact on physical stability.
Since different proteins have different physicochemical charac-
teristics and thus differentmodes of degradation, a generalized pre-
diction of how exactly moisture affects protein degradation rates
cannot be made. However, the presented mechanism of stabiliza-
tion by sugars (i.e. reducing protein local and global mobility) is
applicable for most of these degradation routes. Following the same
strategies as described in Section 4.2, if vitrification (global mobil-
ity) is lost due to moisture exposure, addition of high molecular
weight sugars may be beneficial; whereas whenmoisture increases
chemical reactivity below the Tg, lowermolecularweight sugars are
likely to be more efficient at stabilizing by reducing local mobility.
As not all reactions are equally sensitive to moisture, some even
need water as a reactant, different water contents can also change
the dominant mechanism of degradation, particularly below the
Tg. The Maillard degradation deserves special mention here, as it
involves a set of moisture depending reactions involving reducing
sugars. The degradation rate due to the Maillard reaction generally
increases with increasing moisture content, with little or no degra-
dation below a water activity of 0.25 and with a maximum
around 0.75 [84]. Above this maximum, dilution effects and an
increased global mobility are given as explanation for a decreased
reaction rate [11]. Because of the Maillard reaction, non-reducing
sugars are preferably used for protein stabilization. Should sugars
with reducing groups be used, moisture content should be mini-
mized and factors like pH should also be carefully chosen [85].
In general, drying more is thus beneficial, however, reduced
moisture levels are not always better for protein stability. Multiple
studies found that when stabilized protein formulations were
dried beyond a critical point (e.g. <1% moisture content) degrada-
tion rates would increase again [11,86]. When several enzymes
were dried without stabilizers, drying below 10% water content
resulted in complete loss of functionality [87]. Using the previously
presented hypotheses, over-drying can be interpreted as a critical
loss of protein hydrogen bonds and with that an increased local
mobility and reduced stability. Over-drying in the presence of
sugars might therefore be an indication of inefficient hydrogen
bonding of the carbohydrate, either because of the characteristics
of the carbohydrate (e.g. size and molecular flexibility) or by the
drying process used. Over-drying is thus a potential risk for protein
formulations, particularly when large molecularly rigid polysac-
charides are used.5. Conclusion
At this point it should be clear that there is not one single uni-
fying theory which completely explains how sugars stabilize pro-
teins. This is mostly because there is a multitude of potential
degradation routes, which are different for each protein, and which
on top of that are affected differently by various stress conditions.Therefore it is important to first identify potential routes of degra-
dation and identify the expected processing and storage conditions
[88]. When the primary routes of degradation and storage
conditions are known, a strategy can be defined to protect against
specific stresses and degradation pathways. Sugars can decelerate
both chemical and physical degradation pathways of protein in
the solid state by a reduction of local and global mobility through
tight interactions (i.e. hydrogen bonding) with the protein. Sugars
are generally effective in protecting against dehydration, freezing
and thermal stress, but cannot overcome all protein instabilities.
Therefore, other factors such as drying and other formulations
aspects (e.g. pH, buffer strength, purity of excipients and other
excipients such as surfactants) should also be included in the sta-
bilization strategy. For good stabilization, a sugar should form as
much interactions (i.e. hydrogen bonding) with the protein as pos-
sible, thus reducing local mobility, and it should have a sufficiently
high glass transition temperature to maintain vitrification of the
formulation under the planned storage conditions. Furthermore,
the sugar should be miscible with the protein on a molecular level;
preferably be non-reducing or otherwise be stored under
conditions that limit the Maillard reaction; and preferably have a
low tendency to crystallize or be stored under conditions that
prevent surpassing of the Tg. Practically, this will often mean that
disaccharides such as trehalose will be ideal stabilizers as they are
good at forming interactions and reducing local mobility. If how-
ever moisture content cannot be kept low, vitrification is likely
to become problematic. In such situations, larger oligosaccharides
or a combination of disaccharides and polysaccharides can be used
to increase the glass transition temperatures. Effectively the
amount of interactions (i.e. reduction of local mobility) should be
maximized, whilst preventing loss of vitrification. Additionally, at
elevated moisture levels, the use of non-reducing sugars becomes
more critical.Acknowledgements
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